Procter & Gamble manufactures laundry detergents (Tide, Ariel), fabric softeners (Downy), bar soaps (Ivory, Safeguard), shampoos (Head & Shoulders, Pantene), and oral care products (Crest, Oral-B) sold through mass retail and e-commerce channels globally. The company's portfolio of 65+ brands with combined annual sales exceeding $80 billion creates durable pricing power and cross-selling opportunities that competitors struggle to replicate at scale. Near-term growth hinges on volume recovery in developed markets and continued premiumization in emerging economies, where middle-class expansion is driving demand for higher-margin personal care products. PG trades at a 20.4x forward multiple despite 1.5% revenue growth, pricing in stability rather than acceleration; the 30.3% ROE and 22.1% operating margin suggest the business generates substantial cash but offers limited upside unless organic growth re-accelerates or the company deploys capital more aggressively. At current valuations, the stock appears to reflect a mature, well-managed cash generator rather than a compelling opportunity for a concentrated portfolio.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 23 Oct 2026, 12:04 CEST | Fair value | $106 | $113 | $166 |
| 23 Oct 2026, 01:52 CEST | ACCE price target | $166 | $155 | $166 |
| 18 Oct 2026, 17:04 CEST | Fair value | $113 | $111 | $159 |
| 18 Oct 2026, 17:04 CEST | Rating | Overvalued | first publication | $159 |
| 28 Sept 2026, 00:00 CEST | Fair value | $111 | $114 | $146 |
| 17 Sept 2026, 00:00 CEST | ACCE price target | $155 | first publication | $147 |
| 14 Sept 2026, 00:00 CEST | Fair value | $114 | $116 | $145 |
| 12 Sept 2026, 00:00 CEST | Fair value | $116 | $118 | $143 |
| 7 Sept 2026, 00:00 CEST | Fair value | $118 | $119 | $146 |
| 31 Aug 2026, 00:00 CEST | Fair value | $119 | $122 | $143 |
Answered from Procter & Gamble Company (The) Common Stock fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| PG Procter & Gamble Company (The) Common Stock | $161.02 | $106 | 52% above | 24.3x | 30.3% | 85 | 60 |
| OR.PA L'Oreal | €413.00 | €213 | 94% above | 37.0x | 19.4% | 84 | 57 |
| UL Unilever PLC American Depositary Shares (each representing One Ordinary Share) | $67.00 | $70 | 4% below | 13.0x | 31.9% | 75 | 57 |
| UNA.AS Unilever PLC | €59.36 | €60 | 1% below | 13.9x | 31.9% | 75 | 60 |
| ULVR.L Unilever | £49.76 | £38 | 30% above | 13.4x | 31.9% | 75 | 56 |
| CL Colgate-Palmolive Company Common Stock | $97.39 | $71 | 37% above | 37.0x | 267.4% | 72 | 56 |
| RKT.L Reckitt Benckiser Group plc | £55.78 | £61 | 8% below | 12.5x | 48.0% | 83 | 58 |
Where PG ranks against its sector peers on each metric.